trending Market Intelligence /marketintelligence/en/news-insights/trending/x-7Xp_tMGBVnydmvHXyJRA2 content esgSubNav
In This List

Allergan completes $2.9B LifeCell acquisition

Podcast

Street Talk | Episode 94: Recessionary fears in ’22 overblown, Fed could overtighten

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022


Allergan completes $2.9B LifeCell acquisition

Allergan PLC acquired LifeCell Corp. for approximately $2.9 billion in cash.

The acquisition adds LifeCell's portfolio of reconstruction and complex hernia surgery products to Allergan's existing portfolio of medical aesthetic products, breast implants and tissue expanders.

The merger will also give Allergan access to LifeCell's manufacturing and R&D operations in New Jersey.

Guggenheim Securities and Barclays served as financial advisors to Allergan, while Debevoise & Plimpton LLP were Allergan's lead legal counsel.